out the organization to standardize care and improve the outcome for children and adolescents. LEARNING OBJECTIVES (TRAINING GOALS): 1. Discuss development of anticoagulation recommendations which meet Joint Commission's National Patient Safety Goals. 2. Understand how to implement Best Evident Statements into practice to improve child outcomes. METHODS: An interprofessional group consisting of physicians, guideline developers, methodologists, a pharmacist, and a nurse convened to develop anticoagulation care best evidence statements (BESt) based upon the guidelines published by the American College of Chest Physicians (ACCP). These locally developed statements assisted the organization in meeting the Joint Commission's National Patient Safety Goal, safety of using medication. Once developed, implementation began, which included just-in-time education for residents and attending physicians, online training for nursing staff, and training at staff meetings for the pharmacists. With the timely build, implementation, and rollout of a new electronic medical record (EMR) in the organization, the anticoagulation BESts were integrated into the EMR system. RESULTS: Pediatric care recommendations based upon the ACCP published guidelines resulting from the efforts of the interprofessional team were: management of warfarin therapy, management of therapeutic unfractionated heparin, and management of low-molecular-weight heparin therapy. These clinical aspects of the BESts were incorporated into the electronic medical record.
DISCUSSION (CONCLUSION):
A large pediatric organization met and exceeded the Joint Commission National Patient Safety Goal-safely using medications, specifically anticoagulation medications. By developing and implementing three BESt evidence statements, the organization was able to standardize anticoagulation therapy. BESt evidence statements, adapted for the pediatric patient population from the 2008 ACCP guidelines, guide clinicians to safely care for children with potentially harmful drugs. TARGET AUDIENCE(S): 1. Guideline developer 2. Guideline implementer 3. Developer of guideline-based products 4. Quality improvement manager/facilitator 5. Health care policy analyst/policymaker 6. Medical providers and executives 7. Allied health professionals 8. Nurses Hyperglycemia in hospitalized patients is a common and severe condition that is estimated to affect over 38% of all hospitalized patients. Increasing evidence confirms that hyperglycemia leads to poor clinical outcomes, extended hospitalization, disability, and increased mortality. Both the American Diabetes Association and American College of Endocrinology have recommended the establishment of structured guidelines for controlling hyperglycemia in hospitalized diabetic patients. Recently, the Israeli National Diabetes Council has proposed establishing a standardized protocol to provide effective treatment for hyperglycemic hospitalized patients.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Describe the development and introduce the protocol designed to achieve standardized care of patients with hyperglycemia who are hospitalized in medical wards of a tertiary hospital in Jerusalem. 2. Defines and outlines areas of authority and responsibility of nurses and physicians, and offers a precise definition of the patient population. METHODS: A protocol was established by a multidisciplinary team including diabetes specialists, physicians, and nurses. Approval was obtained from the institutional nursing administration, physician's hospital management, and the diabetes unit of the section of Endocrinology. The assumption was that protocol-based practice would improve control of glucose levels of hospitalized patients with hyperglycemia, and would guide insulinbased treatment based on the balas-bolus regimen, with no elevation in hypoglycemia rates. The protocol also expands the autonomy of RNs to monitor and balance glucose levels and specify interfaces with physicians and other team members. RESULTS: Based on published recommendations in the literature and those from the National Diabetes Council of Israel, new guidelines for medical patients were created. The presentation will include the process of creating the guidelines, the protocol itself, and the process of implementation. DISCUSSION (CONCLUSION): Until today, no standardized protocol to treat diabetes medical patients has been applied, despite the fact that there are significant differences in methods of treatment and interventions. These differences are typical between wards and within the same ward among different physicians. Treating diabetic patients, hospitalized in medical wards, based on a recommended protocol guarantees standardization of treatment and better quality. Dental caries remains a substantial problem for many Irish children, in spite of extensive water fluoridation. A limited public dental service (PDS) provides the only free dental care for children up to age 16. Access to non-emergency care starts at age 7 or 8, and levels of untreated decay are high. A review of the PDS service concluded that services were not being delivered in line with current best evidence.
1. Appreciate the challenges to developing guidelines in a setting with no culture of guideline development. 2. Understand the challenges posed by apparently commonsense recommendations. METHODS: The guideline was developed in accordance with the principles of the AGREE Instrument and drawing on the methodology of NICE and SIGN. A guideline development group, representing key stakeholders, worked with a research team to identify, appraise, summarize, and interpret evidence and develop recommendations tailored for the Irish context. RESULTS: The guideline advocates a reorientation of the public dental service towards early identification of children at high caries risk, using non-dental health professionals to identify high-caries-risk preschool children. Systematic caries risk assessment using a specially developed and piloted Caries Risk Assessment Checklist (CRAC) should be completed for all children attending the dentist. Recommendations on the identification of high-caries-risk populations are also presented. Strategies for caries prevention at population, targeted population, and individual levels complete the guideline.
DISCUSSION (CONCLUSION):
This guideline represents the first evidence-based approach to addressing deficiencies in the delivery of public dental services for children in Ireland. Although many recommendations may seem unremarkable, for the PDS, the guideline represents a radical change in how dental care is provided for children. The implementation of this guideline offers major challenges, but also clear potential to improve the oral health of Irish children. 
LEARNING OBJECTIVES (TRAINING GOALS):
1. Identify methods for adapting guidelines for allied health professionals. 2. Assess the dissemination to and implementation of national guidelines by allied health professionals. METHODS: Under the direction of guest editors, both members of the Expert Committee that developed the CDA document, and the editor-in-chief, the CPJ team identified the topics most relevant to pharmacists, summarizing the original 215page document into 48 pages. The summary highlights the CDA recommendations most pertinent to pharmacy practice, and provides original practice tips and key points to facilitate their implementation. All content was reviewed by a minimum of three experts, including pharmacists from different practice settings and physicians, and was adapted from the Canadian Diabetes Association guidelines with their permission. RESULTS: The pharmacist-specific guidelines were translated into French and were published as English and French supplements to CPJ print and online editions (available at www.cpjournal.ca/diabetes) in March 2009. The project was formally recognized by the Canadian Pharmacists Association and Canadian Diabetes Association as part of the "Partners in Progress" initiative. DISCUSSION (CONCLUSION): Evaluation of the impact of these guidelines on pharmacy practice and patients is now underway, funded by the Public Health Agency of Canada (PHAC).
